Kenneth T. Mills
Net Worth

Last updated:

What is Kenneth T. Mills net worth?

The estimated net worth of Mr. Kenneth T. Mills is at least $19,820,175 as of 14 May 2024. He owns shares worth $3,427,453 as insider, has earned $7,412,252 from insider trading and has received compensation worth at least $8,980,470 in null.

What is the salary of Kenneth T. Mills?

Mr. Kenneth T. Mills salary is $997,830 per year as Pres, Chief Executive Officer & Director in null.

How old is Kenneth T. Mills?

Mr. Kenneth T. Mills is 50 years old, born in 1975.

What stocks does Kenneth T. Mills currently own?

As insider, Mr. Kenneth T. Mills owns shares in one company:

Company Title Shares Price per share Total value
(RGNX) Pres, Chief Executive Officer & Director 408,035 $8.4 $3,427,453

What does do?

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, which is in Phase III clinical trial for the treatment of wet age-related macular degeneration. It is also developing RGX-121 that is in Phase I/II clinical trial to treat mucopolysaccharidosis type II;RGX-111, which is in Phase I/II clinical trial for treating mucopolysaccharidosis type I;RGX-181 which is in pre clinic stage for the treatment of late-infantile neuronal ceroid lipofuscinosis type II disease;RGX-202, to treat Duchenne muscular dystrophy which is in phase I/II clinical trial; and RGX-381, to treat the ocular manifestations of CLN2 disease which is in preclinical stage. REGENXBIO Inc. also licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies; and has a collaboration and license agreement with Neurimmune AG to develop novel gene therapies. REGENXBIO Inc. was founded in 2008 and is headquartered in Rockville, Maryland.

RGNX logo
RGNX
$8.4

Kenneth T. Mills insider trading

Mr. Kenneth T. Mills has made 61 insider trades between 2016-2024, according to the Form 4 filled with the SEC. Most recently he sold 15,000 units of RGNX stock worth $237,225 on 14 May 2024.

The largest trade he's ever made was exercising 150,000 units of RGNX stock on 11 Jan 2018. As of 14 May 2024 he still owns at least 408,035 units of RGNX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 15,000 $15.82 $237,225
Option
Common Stock 15,000 $3.76 $56,400
Option
Stock Options (Right to Buy) 15,000 $3.76 $56,400
Sale
Common Stock 15,000 $18.19 $272,865
Option
Stock Options (Right to Buy) 15,000 $3.76 $56,400
Option
Common Stock 15,000 $3.76 $56,400
Option
Common Stock 15,000 $3.76 $56,400
Option
Stock Options (Right to Buy) 15,000 $3.76 $56,400
Sale
Common Stock 15,000 $21.86 $327,945
Option
Common Stock 15,000 $3.76 $56,400
Sale
Common Stock 4,652 $16.47 $76,628
Sale
Common Stock 10,348 $16.89 $174,726
Option
Stock Options (Right to Buy) 15,000 $3.76 $56,400
Sale
Common Stock 45,000 $15.18 $683,010
Option
Common Stock 45,000 $3.76 $169,200
Option
Stock Options (Right to Buy) 45,000 $3.76 $169,200
Sale
Common Stock 45,000 $19.69 $885,825
Option
Stock Options (Right to Buy) 1,500 $0.85 $1,275
Option
Common Stock 1,500 $0.85 $1,275
Option
Common Stock 43,500 $3.76 $163,560
Option
Stock Options (Right to Buy) 43,500 $3.76 $163,560
Option
Employee Stock Option (Right to Buy) 1,500 $3.76 $5,640
Sale
Common Stock 1,500 $40 $60,000
Option
Common Stock 1,500 $3.76 $5,640
Option
Common Stock 1,500 $3.76 $5,640
Sale
Common Stock 1,500 $42.19 $63,285
Option
Employee Stock Option (Right to Buy) 1,500 $3.76 $5,640
Sale
Common Stock 35,000 $2.31 $80,675
Option
Common Stock 35,000 $45.11 $1,578,850
Option
Common Stock 35,000 $2.31 $80,675
Option
Employee Stock Option (Right to Buy) 35,000 $3.76 $131,600
Sale
Common Stock 35,000 $45.11 $1,578,850
Sale
Common Stock 3,000 $3.76 $11,280
Option
Employee Stock Option (Right to Buy) 3,000 $3.76 $11,280
Option
Common Stock 3,000 $40.02 $120,060
Option
Employee Stock Option (Right to Buy) 3,000 $3.76 $11,280
Sale
Employee Stock Option (Right to Buy) 3,000 $3.76 $11,280
Option
Employee Stock Option (Right to Buy) 1,500 $40.25 $60,375
Option
Common Stock 1,500 $40.25 $60,375
Sale
Common Stock 1,500 $40.25 $60,375
Option
Employee Stock Option (Right to Buy) 4,500 $3.76 $16,920
Sale
Common Stock 4,500 $3.76 $16,920
Option
Common Stock 4,500 $3.76 $16,920
Option
Employee Stock Option (Right to Buy) 1,500 N/A N/A
Option
Common Stock 1,500 N/A N/A
Sale
Common Stock 1,500 N/A N/A
Option
Common Stock 6,500 N/A N/A
Option
Employee Stock Option (Right to Buy) 6,500 N/A N/A
Sale
Common Stock 6,500 $43.89 $285,305
Sale
Common Stock 6,500 N/A N/A
Option
Common Stock 1,500 N/A N/A
Sale
Common Stock 1,500 N/A N/A
Option
Employee Stock Option (Right to Buy) 1,500 N/A N/A
Option
Common Stock 6,500 N/A N/A
Option
Employee Stock Option (Right to Buy) 6,500 N/A N/A
Sale
Common Stock 6,500 N/A N/A
Sale
Common Stock 6,500 N/A N/A
Option
Common Stock 4,500 N/A N/A
Option
Employee Stock Option (Right to Buy) 4,500 N/A N/A
Sale
Common Stock 4,500 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Option
Common Stock 15,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 15,000 N/A N/A
Option
Common Stock 4,500 N/A N/A
Option
Employee Stock Option (Right to Buy) 4,500 N/A N/A
Sale
Common Stock 4,500 N/A N/A
Option
Employee Stock Option (Right to Buy) 5,000 N/A N/A
Option
Common Stock 5,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 15,000 N/A N/A
Option
Common Stock 15,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Option
Common Stock 15,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 15,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Option
Common Stock 15,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 15,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 15,000 N/A N/A
Option
Common Stock 15,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Option
Common Stock 15,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 15,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 15,000 N/A N/A
Option
Common Stock 15,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Option
Common Stock 15,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 15,000 N/A N/A
Option
Common Stock 45,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 45,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Sale
Common Stock 20,000 N/A N/A
Sale
Common Stock 20,000 $64.23 $1,284,500
Sale
Common Stock 20,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Sale
Common Stock 20,000 N/A N/A
Sale
Common Stock 20,000 N/A N/A
Sale
Common Stock 7,510 N/A N/A
Sale
Common Stock 7,510 N/A N/A
Sale
Common Stock 7,510 $66.66 $500,579
Option
Employee Stock Option (Right to Buy) 145,000 N/A N/A
Option
Common Stock 145,000 N/A N/A
Sale
Common Stock 7,510 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 $64.98 $324,880
Sale
Common Stock 10,000 N/A N/A
Sale
Common Stock 10,000 $47.61 $476,100
Sale
Common Stock 10,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Option
Common Stock 150,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 150,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 30,000 N/A N/A
Option
Common Stock 30,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Sale
Common Stock 10,500 N/A N/A
Option
Employee Stock Option (Right to Buy) 23,530 N/A N/A
Option
Common Stock 23,530 N/A N/A
Sale
Common Stock 6,500 N/A N/A
Sale
Common Stock 6,500 N/A N/A
Sale
Common Stock 6,500 N/A N/A
Sale
Common Stock 15,440 N/A N/A
Option
Common Stock 125,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 125,000 N/A N/A

key executives

executives and other stock owners filed with the SEC: